What is Evommune, Inc.?
operates as a clinical-stage biotechnology company in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
operates as a clinical-stage biotechnology company in the United States. The company develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. The company is listed on the NYSE in USA, operating in the Healthcare sector, with a market capitalisation of 291.10M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.